Physician profile
Glenn E Partin
NPI 1124015151
$3,771.67
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,008 · 2020: $316 · 2021: $1,651 · 2022: $781 · 2023: $16.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $712.64 | 2019-2022 | |
| Glaukos Corporation | $509.07 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $346.82 | 2021-2022 | |
| The Cameron-Ehlen Group, INC. | $305.22 | 2021 | |
| Allergan, INC. | $283.62 | 2020-2022 | |
| Dompe US, INC. | $254.28 | 2021 | |
| Sun Pharmaceutical Industries INC. | $245.78 | 2021-2022 | |
| Optos, INC. | $212.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $166.51 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $160.13 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $133.56 | 2020-2022 | |
| Kala Pharmaceuticals, INC. | $122.00 | 2021 | |
| Oyster Point Pharma, INC. | $115.75 | 2022 | |
| Shire North American Group INC | $104.16 | 2019 | |
| Staar Surgical Company | $31.14 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $25.05 | 2022 | |
| Abbvie INC. | $16.50 | 2023 | |
| Abb Con-Cise Optical Group LLC | $14.21 | 2019 | |
| Coopervision INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Partin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.